Retrophin, Inc.

Biestek, Marek

Shkreli, Martin

Vaino, Andrew

Martin Shkreli

Andrew Vaino

Marek Biestek

Compounds having the following formula (E): or a pharmaceutically acceptable salt thereof, wherein R, R', R&#x2033;, X and n are as defined herein are provided. Methods comprising use of such compounds for the treatment of neurologic disorders, such as pantothenate kinase-associated neurodegeneration, and pharmaceutical compositions containing such compounds, and their use in treatment of neurologic disorders are also provided.

Pantothenate derivatives for the treatment of neurological disorders

Compounds having the following formula (E): Formula E or a pharmaceutically acceptable salt thereof, wherein R, R', R&#x2033;, X and n are as defined herein are provided. Methods comprising use of such compounds for the treatment of neurologic disorders, such as pantothenate kinase-associated neurodegeneration, and pharmaceutical compositions containing such compounds, and their use in treatment of neurologic disorders are also provided. 

The present disclosure relates to pantothenate derivatives for the treatment of neurologic disorders (such as pantothenate kinase-associated neurodegeneration), pharmaceutical compositions containing such compounds, and their use in treatment of neurologic disorders.

Growing community of inventors

New York, NY, United States of America

Martin Shkreli